Novo Nordisk
NVO
907 hedge funds and large institutions have $13.8B invested in Novo Nordisk in 2022 Q3 according to their latest regulatory filings, with 74 funds opening new positions, 309 increasing their positions, 330 reducing their positions, and 85 closing their positions.
47% more call options, than puts
Call options by funds: $183M | Put options by funds: $125M
6% less repeat investments, than reductions
Existing positions increased: 309 | Existing positions reduced: 330
1.02% less ownership
Funds ownership: 16.96% → 15.94% (-1%)
3% less funds holding
Funds holding: 933 → 907 (-26)
13% less first-time investments, than exits
New positions opened: 74 | Existing positions closed: 85
16% less capital invested
Capital invested by funds: $16.3B → $13.8B (-$2.53B)
28% less funds holding in top 10
Funds holding in top 10: 39 → 28 (-11)
Top Buyers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
BlackRock
New York
|
+$129M |
| 2 |
EVM
Eaton Vance Management
Boston,
Massachusetts
|
+$86.7M |
| 3 |
Capital World Investors
Los Angeles,
California
|
+$74.2M |
| 4 |
First Trust Advisors
Wheaton,
Illinois
|
+$71.6M |
| 5 |
GGHC
Gilder Gagnon Howe & Co
New York
|
+$53.8M |
Top Sellers
| Rank | Fund | Capital Flow |
|---|---|---|
| 1 |
Fisher Asset Management
Camas,
Washington
|
-$534M |
| 2 |
Renaissance Technologies
New York
|
-$238M |
| 3 |
Arrowstreet Capital
Boston,
Massachusetts
|
-$186M |
| 4 |
Lord, Abbett & Co
Jersey City,
New Jersey
|
-$64.4M |
| 5 |
Healthcare of Ontario Pension Plan (HOOPP) Trust Fund
Toronto,
Ontario, Canada
|
-$64.2M |
NVO Hedge Fund Activity: Q3 2022 in Review
907 of the 5,805 institutional investors tracked by Wall St. Rank reported a position in Novo Nordisk (NVO) for Q3 2022, worth a combined $13.8B — down 16% from $16.3B a quarter earlier.
Sellers outnumbered buyers: 85 funds closed out of NVO and 74 opened new positions — a net loss of 11 holders — while 330 trimmed existing stakes and 309 added.
The largest buyer was BlackRock, adding an estimated $129M. The largest seller was Fisher Asset Management, cutting an estimated $534M.
- 907 institutional investors held Novo Nordisk (NVO) as of Q3 2022, down from 933 in Q2 2022.
- Funds reported $13.8B of Novo Nordisk stock for Q3 2022, down 16% quarter-over-quarter.
- 74 funds opened new Novo Nordisk positions in Q3 2022 and 85 closed out, a net change of -11 holders.
- The largest Novo Nordisk buyer in Q3 2022 was BlackRock, an estimated $129M added.
- The largest Novo Nordisk seller in Q3 2022 was Fisher Asset Management, an estimated $534M sold.
Based on aggregated 13F filings for Q3 2022.